TradeWorx’s iShares Biotechnology ETF IBB Stock Holding History

TradeWorx’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-3,162	Closed	-$239K	–	419
2013 Q4	$239K	Buy	+3,162	New	+$224K	0.1%	333

Other funds holding IBB

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

TradeWorx's IBB Position: Q1 2014 in Review

TradeWorx sold out of iShares Biotechnology ETF (IBB) in Q1 2014, closing a stake of 3,162 shares — an estimated $239K sold.

TradeWorx first reported a position in IBB in Q4 2013 and held it in 1 quarter. The position peaked at $239K in Q4 2013. 288 funds tracked by Wall St. Rank hold IBB as of Q1 2014.

TradeWorx reported no remaining iShares Biotechnology ETF position as of Q1 2014 after selling out during the quarter.
TradeWorx sold 3,162 iShares Biotechnology ETF shares in Q1 2014, an estimated $239K.
TradeWorx first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 1 quarter.
TradeWorx's iShares Biotechnology ETF position peaked at $239K in Q4 2013.
288 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2014.

Based on TradeWorx's 13F filing for Q1 2014, filed 2 Jun 2014.